Resverlogix Corp. (RVX)

CBOE Canada
Currency in CAD
0.045
0.000(0.00%)
Closed
Earnings results expected in 14 days
Fair Value
Day's Range
0.0450.045
52 wk Range
0.0400.090
Key Statistics
Edit
Bid/Ask
0.04 / 0.05
Prev. Close
0.045
Open
0.045
Day's Range
0.045-0.045
52 wk Range
0.04-0.09
Volume
2K
Average Volume (3m)
14.93K
1-Year Change
-25%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RVX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
No news in this category
Looks like there are no results in this news category

Resverlogix Corp. Company Profile

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company’s lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary syndrome, and post COVID-19 conditions. It has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company is headquartered in Calgary, Canada.

Compare RVX to Peers and Sector

Metrics to compare
RVX
Peers
Sector
Relationship
P/E Ratio
0.0x−2.8x−0.6x
PEG Ratio
0.00−0.120.00
Price/Book
0.0x0.3x2.6x
Price / LTM Sales
0.0x3.7x3.0x
Upside (Analyst Target)
0.0%246.3%51.6%
Fair Value Upside
Unlock0.6%9.3%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Resverlogix Corp. (RVX) Stock Price Today?

The Resverlogix Corp. stock price today is 0.045

What Stock Exchange Does Resverlogix Corp. Trade On?

Resverlogix Corp. is listed and trades on the CBOE Canada stock exchange.

What Is the Stock Symbol for Resverlogix Corp.?

The stock symbol for Resverlogix Corp. is "RVX."

What Is the Resverlogix Corp. Market Cap?

As of today, Resverlogix Corp. market cap is 14.16M.

What is Resverlogix Corp. Earnings Per Share?

The Resverlogix Corp. EPS is -0.14.

What Is the Next Resverlogix Corp. Earnings Date?

Resverlogix Corp. will release its next earnings report on 31 Mar 2025.

From a Technical Analysis Perspective, Is RVX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.